Skip to main content
. Author manuscript; available in PMC: 2018 Jan 1.
Published in final edited form as: Br J Dermatol. 2016 Dec 7;176(1):262–264. doi: 10.1111/bjd.14771

Table 2.

Association between PFTs, pulmonary symptoms, and ILD among patients with abnormal PFTs and CT available for review

No ILD
(n = 24)
ILD
(n = 15)
p-valuea
PFT pattern
 Isolated low DLCO 11 (46%) 5 (44%) 0.52
 Restriction 6 (25%) 6 (40%) 0.48
 Obstruction 4 (17%) 0 (0%) 0.15
 Mixed 0 (0%) 2 (13%) 0.14
 Indeterminate 3 (12%) 2 (13%) 1.0
DLCO % predicted 70 [64, 78] 62 [54, 70] 0.06
FVC % predicted 81 [76, 96] 76 [68, 86] 0.08
TLC % predicted 90 [74, 99] 77 [72, 84] 0.02
Dyspnea 8 (33%) 10 (67%) 0.06
Cough 5 (21%) 5 (33%) 0.46
Neither 14 (58%) 5 (33%) 0.19

Median [IQR] compared with Wilcoxon rank-sum, Number (%) compared with Fisher’s exact test.

a

No p-values met statistical significance after Bonferroni correction for multiple comparisons.

PFT: pulmonary function tests, CT: computed tomography scan of the chest, ILD: interstitial lung disease, DLCO: diffusion capacity for carbon monoxide, FVC: forced vital capacity, TLC: total lung capacity